Today: 12 May 2026
Sandisk Stock (SNDK) Week Ahead: Why March 11 Matters
7 March 2026
2 mins read

Sandisk Stock (SNDK) Week Ahead: Why March 11 Matters

NEW YORK, March 7, 2026, 14:59 EST.

  • Sandisk finished Friday at $527.33, falling 6.8% for the session and shedding roughly 17% over the week.
  • Management will appear at Cantor’s Global Technology & Industrial Growth Conference on Wednesday, March 11. That’s also when the U.S. is set to report February consumer price index data.
  • Shares of Micron, Western Digital, and Seagate declined on Friday, a clear sign the selloff was hitting memory and storage stocks as well.

Sandisk Corporation (NASDAQ: SNDK) slid 6.8% Friday to $527.33, hit by the broad market selloff and now down about 17% over the last five sessions. Next up: Sandisk execs are set to appear at Cantor’s Global Technology & Industrial Growth Conference on Wednesday, as the U.S. prepares to release February consumer-price numbers that morning.

Sandisk’s January forecast grabbed attention, dropping right in the midst of a sweeping memory chip shortage investors see dragging into 2027. For the fiscal third quarter, the company put revenue at $4.4 billion to $4.8 billion, and projected adjusted earnings in a $12 to $14 per share band—well ahead of what analysts were expecting. Second-quarter datacenter revenue? Up 64% over the prior quarter.

NAND flash—vital for solid-state drives and memory cards—is now facing fresh pressure as data centers race to scale up for AI. Back in January, Chief Executive David Goeckeler told Reuters that major AI customers focused on inference, the stage where models generate answers, were prioritizing secure supply rather than squeezing prices. “Customers prefer supply over price,” he said. Reuters

Friday’s drop didn’t stop at Sandisk. Wall Street capped its roughest week since October, hammered by a surge in oil and a surprise 92,000 drop in U.S. payrolls for February. Shares across the memory space took the hit: Micron tumbled 6.7%, Western Digital slid 5.3%, and Seagate dropped 4.0%. It was a broad rout.

March 11 shapes up with a pair of events. The February CPI lands at 8:30 a.m. ET, and later, Sandisk steps up for its Cantor presentation at 2:50 p.m. ET. Investors are watching for new color on enterprise SSD adoption, pricing trends, and supply lines, especially since Sandisk and Kioxia pushed their supply pact out to 2034 back in January.

The share overhang hasn’t gone away. On Feb. 18, Reuters said Western Digital offloaded part of its Sandisk stake in a $3.17 billion secondary deal, but the former parent is still sitting on roughly 1.7 million Sandisk shares—stock it could sell off down the road as it looks to pare debt.

The setup isn’t straightforward, judging by analyst notes. Morgan Stanley, following Sandisk’s January results, pointed out that “Earnings are above the long-term trend” and may hold up “for as long as the AI trajectory remains this robust.” Morningstar’s William Kerwin, though, flagged “the biggest question mark is how long this investment lasts” in his March 6 note, while acknowledging supply constraints should keep things favorable “the next two years at least.” Reuters

Goeckeler is sticking to his upbeat stance. In Sandisk’s January earnings update, he pointed to the quarter’s “agility” and maintained that a “structural reset” in supply would underpin “disciplined growth” and “industry-leading financial performance.” Sandisk

But sentiment shifts quickly in this market. Reuters pointed out back in January that memory is a notoriously cyclical business, and this week Kerwin flagged fresh risks: too much supply or a demand pullback could squeeze both profits and the stock. If oil-driven inflation shows up in a stronger CPI print, that’s one more headache for a name already down 17% over just five sessions.

Here’s the lineup: CPI lands ahead of the bell March 11, Sandisk’s execs step up later, and traders will be hunting for signs that January’s flash demand surge hasn’t already started to cool. Investors want to see if the previous outlook is still in play.

Stock Market Today

  • ASX set to dip after budget scraps 50% capital gains tax discount
    May 12, 2026, 5:32 PM EDT. The Australian federal budget removed the 50% capital gains tax (CGT) discount on investments, aiming to correct undercompensation for inflation's impact on shares. This move targets intergenerational housing inequality by shifting investment incentives from property to stocks and new properties. While some investors like Liam Walsh, with $3 million in growth shares, anticipate personal losses, they acknowledge the policy's broader merit. Economists warn that the prior CGT settings favored property wealth accumulation, limiting opportunities for new investors. The reforms are expected to encourage investment decisions driven by economic factors rather than tax avoidance, potentially reshaping Australia's wealth-building landscape.

Latest article

Tesla Stock Falls as Hot Inflation and Robotaxi Doubts Test the AI Premium

Tesla Stock Falls as Hot Inflation and Robotaxi Doubts Test the AI Premium

12 May 2026
Tesla shares fell 2.7% to $433.45 after U.S. inflation data pushed Treasury yields higher and Reuters reported long waits and spotty robotaxi service in Texas. The stock swung from a high of $447.56 to a low of $422.39. Tesla’s valuation remains near $1.53 trillion, with a price-to-earnings ratio close to 398. Management cited cautious robotaxi rollout and increased 2026 capital spending above $25 billion.
Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

12 May 2026
Ernexa Therapeutics shares jumped 58.5% to $11.43 Tuesday after renewed investor focus on its preclinical ovarian-cancer therapy ERNA-101, following a May 11 investor event. Trading volume reached about 18.85 million shares. The company reported $8.3 million in cash as of April 30, less than needed for its 12-month plan, and may use an at-the-market stock sale to raise funds.
UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

12 May 2026
UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
Apple Stock Week Ahead: March 11 Rollout and CPI Test AAPL After Friday Pullback
Previous Story

Apple Stock Week Ahead: March 11 Rollout and CPI Test AAPL After Friday Pullback

Meta Stock Week Ahead: Why CPI, EU Pressure and AI Costs Could Drive the Next Move
Next Story

Meta Stock Week Ahead: Why CPI, EU Pressure and AI Costs Could Drive the Next Move

Go toTop